Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
48.92
-2.45 (-4.77%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Tarsus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-115.55-135.89-62.09-13.83-26.81
Upgrade
Depreciation & Amortization
1.230.880.330.310.1
Upgrade
Other Amortization
0.480.390.31--
Upgrade
Loss (Gain) From Sale of Assets
---0.07-
Upgrade
Loss (Gain) From Sale of Investments
-3.62-3.42-1.050.59-
Upgrade
Stock-Based Compensation
27.8219.8313.468.460.84
Upgrade
Other Operating Activities
2.780.420.976.783.28
Upgrade
Change in Accounts Receivable
-30.14-16.62--0.02
Upgrade
Change in Inventory
-2.05-3.11---
Upgrade
Change in Accounts Payable
40.3413.240.823.883.24
Upgrade
Change in Other Net Operating Assets
-4.316.79-1.77-2.51-1.8
Upgrade
Operating Cash Flow
-83.03-117.49-49.033.75-21.14
Upgrade
Capital Expenditures
-1.57-1.5-0.51-0.59-0.46
Upgrade
Sale (Purchase) of Intangibles
-5-4---
Upgrade
Investment in Securities
-192.63146.11-144.12--
Upgrade
Investing Cash Flow
-199.2140.6-144.63-0.59-0.46
Upgrade
Long-Term Debt Issued
751020--
Upgrade
Net Debt Issued (Repaid)
751020--
Upgrade
Issuance of Common Stock
105.69120.1874.940.3292.04
Upgrade
Other Financing Activities
-26.04--0.95-0.3-
Upgrade
Financing Cash Flow
154.66130.1893.990.02131.77
Upgrade
Net Cash Flow
-127.57153.29-99.673.18110.18
Upgrade
Free Cash Flow
-84.59-119-49.543.16-21.59
Upgrade
Free Cash Flow Margin
-46.24%-682.04%-191.88%5.54%-
Upgrade
Free Cash Flow Per Share
-2.25-4.05-2.010.15-3.48
Upgrade
Cash Interest Paid
7.662.881.68--
Upgrade
Levered Free Cash Flow
-50.48-74.49-27.354.74-14.49
Upgrade
Unlevered Free Cash Flow
-46.05-72.78-26.294.74-14.49
Upgrade
Change in Net Working Capital
-6.83-1.490.37-4.15-1.9
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q